Literature DB >> 9746488

Demonstration of an early and a late phase of ischemic preconditioning in mice.

Y Guo1, W J Wu, Y Qiu, X L Tang, Z Yang, R Bolli.   

Abstract

It is unknown whether ischemic preconditioning (PC; either early or late) occurs in the mouse. The goal of this study was to answer this question and to develop a reliable and physiologically relevant murine model of both early and late ischemic PC. A total of 201 mice were used. In nonpreconditioned open-chest animals subjected to 30 min of coronary occlusion followed by 24 h of reperfusion, infarct size (tetrazolium staining) averaged 52% of the region at risk. When the 30-min occlusion was performed 10 min after a PC protocol consisting of six cycles of 4-min occlusion and 4-min reperfusion, infarct size was reduced by 75%, indicating an early PC effect. When the 30-min occlusion was performed 24 h after the same PC protocol, infarct size was reduced by 48%, indicating a late PC effect. In mice in which the 30-min occlusion was followed by 4 h of reperfusion, infarct size was similar to that observed after 24 h of reperfusion, indicating that a 4-h reperfusion interval is sufficient to detect the final extent of cell death in this model. Fundamental physiological variables (body temperature, arterial oxygenation, acid-base balance, heart rate, and arterial pressure) were measured and found to be within normal limits. Taken together, these results demonstrate that, in the mouse, a robust infarct-sparing effect occurs during both the early and the late phases of ischemic PC, although the early phase is more powerful. This murine model is physiologically relevant, provides reliable measurements, and should be useful for elucidating the cellular mechanisms of ischemic PC in genetically engineered animals.

Entities:  

Mesh:

Year:  1998        PMID: 9746488      PMCID: PMC3701297          DOI: 10.1152/ajpheart.1998.275.4.H1375

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  49 in total

Review 1.  Myocardial adaptation, stress proteins, and the second window of protection.

Authors:  M S Marber; D M Yellon
Journal:  Ann N Y Acad Sci       Date:  1996-09-30       Impact factor: 5.691

2.  Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes.

Authors:  H Ohkubo; H Kawakami; Y Kakehi; T Takumi; H Arai; Y Yokota; M Iwai; Y Tanabe; M Masu; J Hata
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

3.  Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved.

Authors:  Y Qiu; P Ping; X L Tang; S Manchikalapudi; A Rizvi; J Zhang; H Takano; W J Wu; S Teschner; R Bolli
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning.

Authors:  R Bolli; S Manchikalapudi; X L Tang; H Takano; Y Qiu; Y Guo; Q Zhang; A K Jadoon
Journal:  Circ Res       Date:  1997-12       Impact factor: 17.367

5.  Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits.

Authors:  H Takano; S Manchikalapudi; X L Tang; Y Qiu; A Rizvi; A K Jadoon; Q Zhang; R Bolli
Journal:  Circulation       Date:  1998-08-04       Impact factor: 29.690

6.  Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning.

Authors:  G F Baxter; M S Marber; V C Patel; D M Yellon
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

7.  "Normothermic range" temperature affects myocardial infarct size.

Authors:  G L Chien; R A Wolff; R F Davis; D M van Winkle
Journal:  Cardiovasc Res       Date:  1994-07       Impact factor: 10.787

8.  A comparative study with various anesthetics in mice (pentobarbitone, ketamine-xylazine, carfentanyl-etomidate).

Authors:  W Erhardt; A Hebestedt; G Aschenbrenner; B Pichotka; G Blümel
Journal:  Res Exp Med (Berl)       Date:  1984

9.  Blood pressure and fluid-electrolyte balance in ANF-transgenic mice on high- and low-salt diets.

Authors:  A T Veress; C K Chong; L J Field; H Sonnenberg
Journal:  Am J Physiol       Date:  1995-07

10.  Salt-sensitive hypertension in transgenic mice overexpressing Na(+)-proton exchanger.

Authors:  M Kuro-o; K Hanaoka; Y Hiroi; T Noguchi; Y Fujimori; S Takewaki; M Hayasaka; H Katoh; A Miyagishi; R Nagai
Journal:  Circ Res       Date:  1995-01       Impact factor: 17.367

View more
  95 in total

1.  Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning.

Authors:  Y Guo; R Bolli; W Bao; W J Wu; R G Black; S S Murphree; C A Salvatore; M A Jacobson; J A Auchampach
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

2.  Endoplasmic reticulum stress-dependent activation of ATF3 mediates the late phase of ischemic preconditioning.

Authors:  Alan C Brooks; Yiru Guo; Mahavir Singh; James McCracken; Yu-Ting Xuan; Sanjay Srivastava; Roberto Bolli; Aruni Bhatnagar
Journal:  J Mol Cell Cardiol       Date:  2014-08-23       Impact factor: 5.000

3.  A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection.

Authors:  Ludovic Gomez; Melanie Paillard; Megan Price; Qun Chen; Geoffrey Teixeira; Sarah Spiegel; Edward J Lesnefsky
Journal:  Basic Res Cardiol       Date:  2011-10-15       Impact factor: 17.165

4.  Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts.

Authors:  Rachel J Keith; Petra Haberzettl; Elena Vladykovskaya; Bradford G Hill; Karin Kaiserova; Sanjay Srivastava; Oleg Barski; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2008-11-11       Impact factor: 5.192

Review 5.  Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.

Authors:  Roberto Bolli; Ken Shinmura; Xian-Liang Tang; Eitaro Kodani; Yu-Ting Xuan; Yiru Guo; Buddhadeb Dawn
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

6.  Ischemic and pharmacological preconditioning induces further delayed protection in transgenic mouse cardiac myocytes over-expressing adenosine A1 receptors (A1AR): role of A1AR, iNOS and K(ATP) channels.

Authors:  Mohammed A Nayeem; G Paul Matherne; S Jamal Mustafa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-25       Impact factor: 3.000

7.  The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs.

Authors:  Steven P Jones; Xian-Liang Tang; Yiru Guo; Charles Steenbergen; David J Lefer; Rakesh C Kukreja; Maiying Kong; Qianhong Li; Shashi Bhushan; Xiaoping Zhu; Junjie Du; Yibing Nong; Heather L Stowers; Kazuhisa Kondo; Gregory N Hunt; Traci T Goodchild; Adam Orr; Carlos C Chang; Ramzi Ockaili; Fadi N Salloum; Roberto Bolli
Journal:  Circ Res       Date:  2014-12-11       Impact factor: 17.367

8.  CRYAB and HSPB2 deficiency alters cardiac metabolism and paradoxically confers protection against myocardial ischemia in aging mice.

Authors:  Ivor J Benjamin; Yiru Guo; Sathyanarayanan Srinivasan; Sihem Boudina; Ryan P Taylor; Namakkal S Rajasekaran; Roberta Gottlieb; Eric F Wawrousek; E Dale Abel; Roberto Bolli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-09-14       Impact factor: 4.733

9.  Mechanism of cyclooxygenase-2 upregulation in late preconditioning.

Authors:  Yu-Ting Xuan; Yiru Guo; Yanqing Zhu; Hui Han; Robert Langenbach; Buddhadeb Dawn; Roberto Bolli
Journal:  J Mol Cell Cardiol       Date:  2003-05       Impact factor: 5.000

10.  Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model.

Authors:  Sheryl E Koch; Michael Tranter; Nathan Robbins; Kristin Luther; Umesh Singh; Min Jiang; Xiaoping Ren; Trisha Tee; Leah Smith; Priyanka Varma; W Keith Jones; Jack Rubinstein
Journal:  J Cardiovasc Pharmacol Ther       Date:  2012-12-14       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.